Genetic risk converges on regulatory networks mediating early type 2 diabetes.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
04 Dec 2023
Historique:
received: 02 12 2021
accepted: 28 09 2023
pubmed: 5 12 2023
medline: 5 12 2023
entrez: 4 12 2023
Statut: aheadofprint

Résumé

Type 2 diabetes mellitus (T2D), a major cause of worldwide morbidity and mortality, is characterized by dysfunction of insulin-producing pancreatic islet β cells

Identifiants

pubmed: 38049589
doi: 10.1038/s41586-023-06693-2
pii: 10.1038/s41586-023-06693-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Kahn, S. E., Hull, R. L. & Utzschneider, K. M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444, 840–846 (2006).
pubmed: 17167471
Halban, P. A. et al. β-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment. Diabetes Care 37, 1751–1758 (2014).
pubmed: 24812433 pmcid: 4179518
Mahajan, A. et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat. Genet. 50, 1505–1513 (2018).
pubmed: 30297969 pmcid: 6287706
Rai, V. et al. Single-cell ATAC-seq in human pancreatic islets and deep learning upscaling of rare cells reveals cell-specific type 2 diabetes regulatory signatures. Mol. Metab. 32, 109–121 (2019).
pubmed: 32029221 pmcid: 6961712
Chiou, J. et al. Single-cell chromatin accessibility identifies pancreatic islet cell type- and state-specific regulatory programs of diabetes risk. Nat. Genet. 53, 455–466 (2021).
pubmed: 33795864 pmcid: 9037575
Ahlqvist, E., Prasad, R. B. & Groop, L. Subtypes of type 2 diabetes determined from clinical parameters. Diabetes 69, 2086–2093 (2020).
pubmed: 32843567
Redondo, M. J. et al. The clinical consequences of heterogeneity within and between different diabetes types. Diabetologia 63, 2040–2048 (2020).
pubmed: 32894314 pmcid: 8498993
Weitz, J., Menegaz, D. & Caicedo, A. Deciphering the complex communication networks that orchestrate pancreatic islet function. Diabetes 70, 17–26 (2020).
pmcid: 7881851
Vujkovic, M. et al. Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis. Nat. Genet. 52, 680–691 (2020).
pubmed: 32541925 pmcid: 7343592
Mahajan, A. et al. Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation. Nat. Genet. 54, 560–572 (2022).
pubmed: 35551307 pmcid: 9179018
Parker, S. C. J. et al. Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants. Proc. Natl Acad. Sci. USA 110, 17921–17926 (2013).
pubmed: 24127591 pmcid: 3816444
Trynka, G. et al. Chromatin marks identify critical cell types for fine mapping complex trait variants. Nat. Genet. 45, 124–130 (2013).
pubmed: 23263488
Pasquali, L. et al. Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants. Nat. Genet. 46, 136–43 (2014).
pubmed: 24413736 pmcid: 3935450
Walker, J. T., Saunders, D. C., Brissova, M. & Powers, A. C. The human islet: mini-organ with mega-impact. Endocr. Rev. 42, bnab010 (2021).
Brissova, M. et al. Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J. Histochem. Cytochem. 53, 1087–1097 (2005).
pubmed: 15923354
Dai, C. et al. Stress-impaired transcription factor expression and insulin secretion in transplanted human islets. J. Clin. Invest. 126, 1857–1870 (2016).
pubmed: 27064285 pmcid: 4855919
Wigger, L. et al. Multi-omics profiling of living human pancreatic islet donors reveals heterogeneous beta cell trajectories towards type 2 diabetes. Nat. Metab. 3, 1017–1031 (2021).
pubmed: 34183850
Camunas-Soler, J. et al. Patch-seq links single-cell transcriptomes to human islet dysfunction in diabetes. Cell Metab. 31, 1017–1031.e4 (2020).
pubmed: 32302527 pmcid: 7398125
Shapira, S. N., Naji, A., Atkinson, M. A., Powers, A. C. & Kaestner, K. H. Understanding islet dysfunction in type 2 diabetes through multidimensional pancreatic phenotyping: The Human Pancreas Analysis Program. Cell Metab. 34, 1906–1913 (2022).
pubmed: 36206763 pmcid: 9742126
Albrechtsen, N. J. W. et al. The liver–α-cell axis and type 2 diabetes. Endocr. Rev. 40, 1353–1366 (2019).
Wu, M. et al. Single-cell analysis of the human pancreas in type 2 diabetes using multi-spectral imaging mass cytometry. Cell Rep. 37, 109919 (2021).
pubmed: 34731614 pmcid: 8609965
Dam, T. J. Pvan et al. CiliaCarta: an integrated and validated compendium of ciliary genes. PLoS ONE 14, e0216705 (2019).
pubmed: 31095607 pmcid: 6522010
Smith, S. B. et al. Rfx6 directs islet formation and insulin production in mice and humans. Nature 463, 775–780 (2010).
pubmed: 20148032 pmcid: 2896718
Patel, K. A. et al. Heterozygous RFX6 protein truncating variants are associated with MODY with reduced penetrance. Nat. Commun. 8, 888 (2017).
pubmed: 29026101 pmcid: 5638866
Varshney, A. et al. Genetic regulatory signatures underlying islet gene expression and type 2 diabetes. Proc. Natl Acad. Sci. USA 114, 2301–2306 (2017).
pubmed: 28193859 pmcid: 5338551
Walker, J. T. et al. Integrated human pseudoislet system and microfluidic platform demonstrates differences in G-protein-coupled-receptor signaling in islet cells. JCI Insight 5, e137017 (2020).
pubmed: 32352931 pmcid: 7259531
Viñuela, A. et al. Genetic variant effects on gene expression in human pancreatic islets and their implications for T2D. Nat. Commun. 11, 4912 (2020).
pubmed: 32999275 pmcid: 7528108
Kahn, S. E., Zraika, S., Utzschneider, K. M. & Hull, R. L. The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality. Diabetologia 52, 1003–1012 (2009).
pubmed: 19326096 pmcid: 2737455
Meier, J. J. & Bonadonna, R. C. Role of reduced β-cell mass versus impaired β-cell function in the pathogenesis of type 2 diabetes. Diabetes Care 36, S113–S119 (2013).
pubmed: 23882035 pmcid: 3920783
Cohrs, C. M. et al. Dysfunction of persisting β cells is a key feature of early type 2 diabetes pathogenesis. Cell Rep. 31, 107469 (2020).
pubmed: 32268101
McCarthy, M. I. Painting a new picture of personalised medicine for diabetes. Diabetologia 60, 793–799 (2017).
pubmed: 28175964 pmcid: 6518376
Chandra, V. et al. RFX6 regulates insulin secretion by modulating Ca
pubmed: 25497100
Piccand, J. et al. Rfx6 maintains the functional identity of adult pancreatic β cells. Cell Rep. 9, 2219–2232 (2014).
pubmed: 25497096 pmcid: 4542305
Choksi, S. P., Lauter, G., Swoboda, P. & Roy, S. Switching on cilia: transcriptional networks regulating ciliogenesis. Development 141, 1427–1441 (2014).
pubmed: 24644260
Piasecki, B. P., Burghoorn, J. & Swoboda, P. Regulatory factor X (RFX)-mediated transcriptional rewiring of ciliary genes in animals. Proc. Natl Acad. Sci. USA 107, 12969–12974 (2010).
pubmed: 20615967 pmcid: 2919930
Kurki, M. I. et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613, 508–518 (2023).
pubmed: 36653562 pmcid: 9849126
Iotchkova, V. et al. GARFIELD classifies disease-relevant genomic features through integration of functional annotations with association signals. Nat. Genet. 51, 343–353 (2019).
pubmed: 30692680 pmcid: 6908448
Gloyn, A. L. et al. Every islet matters: improving the impact of human islet research. Nat. Metab. 4, 970–977 (2022).
pubmed: 35953581
Balamurugan, A. N., Chang, Y., Fung, J. J., Trucco, M. & Bottino, R. Flexible management of enzymatic digestion improves human islet isolation outcome from sub‐optimal donor pancreata. Am. J. Transplant. 3, 1135–1142 (2003).
pubmed: 12919094
Dai, C. et al. Age-dependent human β cell proliferation induced by glucagon-like peptide 1 and calcineurin signaling. J. Clin. Invest. 127, 3835–3844 (2017).
pubmed: 28920919 pmcid: 5617654
Brissova, M. et al. α cell function and gene expression are compromised in type 1 diabetes. Cell Rep. 22, 2667–2676 (2018).
pubmed: 29514095 pmcid: 6368357
Brissova, M. et al. Islet microenvironment, modulated by vascular endothelial growth factor-A signaling, promotes β cell regeneration. Cell Metab. 19, 498–511 (2014).
pubmed: 24561261 pmcid: 4012856
Brissova, M. et al. The Integrated Islet Distribution Program answers the call for improved human islet phenotyping and reporting of human islet characteristics in research articles. Diabetologia 62, 1312–1314 (2019).
pubmed: 31089753 pmcid: 7365209
Kayton, N. S. et al. Human islet preparations distributed for research exhibit a variety of insulin-secretory profiles. Am. J. Physiol. Endocrinol. Metab. 308, E592–E602 (2015).
pubmed: 25648831 pmcid: 4385877
Fitzmaurice, G. M., Laird, N. M. & Ware, J. H. Applied Longitudinal Analysis (Wiley, 2011).
Shultz, L. D. et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2Rγ
pubmed: 15879151
Dai, C. et al. Tacrolimus- and sirolimus-induced human β cell dysfunction is reversible and preventable. JCI Insight 5, e130770 (2020).
pubmed: 31941840 pmcid: 7030815
Dorrell, C. et al. Transcriptomes of the major human pancreatic cell types. Diabetologia 54, 2832 (2011).
pubmed: 21882062
Saunders, D. C. et al. Ectonucleoside triphosphate diphosphohydrolase-3 antibody targets adult human pancreatic β cells for in vitro and in vivo analysis. Cell Metab. 29, 745–754.e4 (2019).
pubmed: 30449685
Dorrell, C. et al. Human islets contain four distinct subtypes of β cells. Nat. Commun. 7, 11756 (2016).
pubmed: 27399229 pmcid: 4942571
Haliyur, R. et al. Human islets expressing HNF1A variant have defective β cell transcriptional regulatory networks. J. Clin. Invest. 129, 246–251 (2018).
pubmed: 30507613 pmcid: 6307934
Marzban, L., Park, K. & Verchere, C. B. Islet amyloid polypeptide and type 2 diabetes. Exp. Gerontol. 38, 347–351 (2003).
pubmed: 12670620
Westermark, P., Andersson, A. & Westermark, G. T. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol. Rev. 91, 795–826 (2011).
pubmed: 21742788
Hart, N. J. et al. Cystic fibrosis–related diabetes is caused by islet loss and inflammation. JCI Insight 3, e98240 (2018).
pubmed: 29669939 pmcid: 5931120
Noguchi, G. M. & Huising, M. O. Integrating the inputs that shape pancreatic islet hormone release. Nat. Metab. 1, 1189–1201 (2019).
pubmed: 32694675 pmcid: 7378277
Black, S. et al. CODEX multiplexed tissue imaging with DNA-conjugated antibodies. Nat. Protoc. 16, 3802–3835 (2021).
pubmed: 34215862 pmcid: 8647621
Blondel, V. D., Guillaume, J.-L., Lambiotte, R. & Lefebvre, E. Fast unfolding of communities in large networks. J. Stat. Mech. Theory Exp. 2008, P10008 (2008).
Luhn, H. P. The automatic creation of literature abstracts. IBM J. Res. Dev. 2, 159–165 (1958).
Schürch, C. M. et al. Coordinated cellular neighborhoods orchestrate antitumoral immunity at the colorectal cancer invasive front. Cell 182, 1341–1359.e19 (2020).
pubmed: 32763154 pmcid: 7479520
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
pubmed: 23104886
Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923–930 (2014).
pubmed: 24227677
Hartley, S. W. & Mullikin, J. C. QoRTs: a comprehensive toolset for quality control and data processing of RNA-Seq experiments. BMC Bioinformatics 16, 224 (2015).
pubmed: 26187896 pmcid: 4506620
Wang, L. et al. Measure transcript integrity using RNA-seq data. BMC Bioinformatics 17, 58 (2016).
pubmed: 26842848 pmcid: 4739097
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
pubmed: 25516281 pmcid: 4302049
Risso, D., Ngai, J., Speed, T. P. & Dudoit, S. Normalization of RNA-seq data using factor analysis of control genes or samples. Nat. Biotechnol. 32, 896–902 (2014).
pubmed: 25150836 pmcid: 4404308
Lee, C., Patil, S. & Sartor, M. A. RNA-Enrich: a cut-off free functional enrichment testing method for RNA-seq with improved detection power. Bioinformatics 32, 1100–1102 (2016).
pubmed: 26607492
Supek, F., Bošnjak, M., Škunca, N. & Šmuc, T. REVIGO summarizes and visualizes long lists of Gene Ontology terms. PLoS ONE 6, e21800 (2011).
pubmed: 21789182 pmcid: 3138752
Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003).
pubmed: 14597658 pmcid: 403769
Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).
pubmed: 30944313 pmcid: 6447622
Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9, 559 (2008).
pubmed: 19114008 pmcid: 2631488
Saeedi, P. et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res. Clin. Pract. 157, 107843 (2019).
pubmed: 31518657
Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
pubmed: 25605792 pmcid: 4402510
Naba, A. et al. The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Mol. Cell Proteomics 11, M111.014647 (2012).
pubmed: 22159717
Breuer, K. et al. InnateDB: systems biology of innate immunity and beyond—recent updates and continuing curation. Nucleic Acids Res. 41, D1228–D1233 (2013).
pubmed: 23180781
Kolberg, L., Raudvere, U., Kuzmin, I., Vilo, J. & Peterson, H. gprofiler2–an R package for gene list functional enrichment analysis and namespace conversion toolset g:Profiler. F1000research 9, ELIXIR–709 (2020).
pubmed: 33564394 pmcid: 7859841
Chen, J. et al. The trans-ancestral genomic architecture of glycemic traits. Nat. Genet. 53, 840–860 (2021).
pubmed: 34059833 pmcid: 7610958
Bailey, T. L. et al. MEME Suite: tools for motif discovery and searching. Nucleic Acids Res. 37, W202–W208 (2009).
pubmed: 19458158 pmcid: 2703892
Weirauch, M. T. et al. Determination and inference of eukaryotic transcription factor sequence specificity. Cell 158, 1431–1443 (2014).
pubmed: 25215497 pmcid: 4163041
Das, S. et al. Next-generation genotype imputation service and methods. Nat. Genet. 48, 1284–1287 (2016).
pubmed: 27571263 pmcid: 5157836
Loh, P.-R. et al. Reference-based phasing using the Haplotype Reference Consortium panel. Nat. Genet. 48, 1443–1448 (2016).
pubmed: 27694958 pmcid: 5096458
Auton, A. et al. A global reference for human genetic variation. Nature 526, 68–74 (2015).
pubmed: 26432245
Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics 25, 1754–1760 (2009).
pubmed: 19451168 pmcid: 2705234
Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078–2079 (2009).
pubmed: 19505943 pmcid: 2723002
Orchard, P., Kyono, Y., Hensley, J., Kitzman, J. O. & Parker, S. C. J. Quantification, dynamic visualization, and validation of bias in ATAC-seq data with ataqv. Cell Syst. 10, 298–306.e4 (2020).
pubmed: 32213349 pmcid: 8245295
Lun, A. T. L. et al. EmptyDrops: distinguishing cells from empty droplets in droplet-based single-cell RNA sequencing data. Genome Biol. 20, 63 (2019).
pubmed: 30902100 pmcid: 6431044
Kang, H. M. et al. Multiplexed droplet single-cell RNA-sequencing using natural genetic variation. Nat. Biotechnol. 36, 89–94 (2018).
pubmed: 29227470
Yang, S. et al. Decontamination of ambient RNA in single-cell RNA-seq with DecontX. Genome Biol. 21, 57 (2020).
pubmed: 32138770 pmcid: 7059395
R Core Team. R: A Language and Environment for Statistical Computing. http://www.R-project.org/ (R Foundation for Statistical Computing, 2020).
Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411 (2018).
pubmed: 29608179 pmcid: 6700744
Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888–1902.e21 (2019).
pubmed: 31178118 pmcid: 6687398
Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573–3587.e29 (2021).
pubmed: 34062119 pmcid: 8238499
Thibodeau, A. et al. AMULET: a novel read count-based method for effective multiplet detection from single nucleus ATAC-seq data. Genome Biol. 22, 252 (2021).
pubmed: 34465366 pmcid: 8408950
Speir, M. L. et al. UCSC Cell Browser: visualize your single-cell data. Bioinformatics 37, 4578–4580 (2021).
pubmed: 34244710 pmcid: 8652023
Sande, B. Vde et al. A scalable SCENIC workflow for single-cell gene regulatory network analysis. Nat. Protoc. 15, 2247–2276 (2020).
pubmed: 32561888
Quinlan, A. R. BEDTools: the Swiss‐army tool for genome feature analysis. Curr. Protoc. Bioinform. 47, 11.12.1–11.12.34 (2014).
Zhang, Y. et al. Model-based analysis of ChIP-seq (MACS). Genome Biol. 9, R137–R137 (2008).
pubmed: 18798982 pmcid: 2592715
Kent, W. J., Zweig, A. S., Barber, G., Hinrichs, A. S. & Karolchik, D. BigWig and BigBed: enabling browsing of large distributed datasets. Bioinformatics 26, 2204–2207 (2010).
pubmed: 20639541 pmcid: 2922891
Grant, C. E., Bailey, T. L. & Noble, W. S. FIMO: scanning for occurrences of a given motif. Bioinformatics 27, 1017–1018 (2011).
pubmed: 21330290 pmcid: 3065696
Kheradpour, P. & Kellis, M. Systematic discovery and characterization of regulatory motifs in ENCODE TF binding experiments. Nucleic Acids Res. 42, 2976–2987 (2014).
pubmed: 24335146
Jolma, A. et al. DNA-binding specificities of human transcription factors. Cell 152, 327–339 (2013).
pubmed: 23332764
Chinwalla, A. T. et al. Initial sequencing and comparative analysis of the mouse genome. Nature 420, 520–562 (2002).
pubmed: 12466850
Bailey, T. L. & Elkan, C. Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc. Int. Conf. Intell. Syst. Mol. Biol. 2, 28–36 (1994).
pubmed: 7584402
Bailey, T. L. DREME: motif discovery in transcription factor ChIP–seq data. Bioinformatics 27, 1653–1659 (2011).
pubmed: 21543442 pmcid: 3106199
Bailey, T. L., Johnson, J., Grant, C. E. & Noble, W. S. The MEME suite. Nucleic Acids Res. 43, W39–W49 (2015).
pubmed: 25953851
Bowden, J., Smith, G. D. & Burgess, S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 44, 512–525 (2015).
pubmed: 26050253 pmcid: 4469799
Bowden, J., Smith, G. D., Haycock, P. C. & Burgess, S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet. Epidemiol. 40, 304–314 (2016).
pubmed: 27061298 pmcid: 4849733
Ye, T., Shao, J. & Kang, H. Debiased inverse-variance weighted estimator in two-sample summary-data Mendelian randomization. Ann. Stat. 49, 2079–2100 (2021).
Verbanck, M., Chen, C.-Y., Neale, B. & Do, R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat. Genet. 50, 693 (2018).
pubmed: 29686387 pmcid: 6083837
Yavorska, O. O. & Burgess, S. MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data. Int. J. Epidemiol. 46, 1734–1739 (2017).
pubmed: 28398548 pmcid: 5510723
Sudlow, C. et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, e1001779 (2015).
pubmed: 25826379 pmcid: 4380465
McCarthy, S. et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat. Genet. 48, 1279–1283 (2016).
pubmed: 27548312 pmcid: 5388176
Loh, P.-R. et al. Efficient Bayesian mixed model analysis increases association power in large cohorts. Nat. Genet. 47, 284–290 (2015).
pubmed: 25642633 pmcid: 4342297
Bonner-Weir, S. & O’Brien, T. D. Islets in type 2 diabetes: in honor of Dr. Robert C. Turner. Diabetes 57, 2899–2904 (2008).
pubmed: 18971437 pmcid: 2570382
Sakuraba, H. et al. Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type II diabetic patients. Diabetologia 45, 85–96 (2002).
pubmed: 11845227
Butler, A. E. et al. β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52, 102–110 (2003).
pubmed: 12502499
Rahier, J., Guiot, Y., Goebbels, R. M., Sempoux, C. & Henquin, J. C. Pancreatic β‐cell mass in European subjects with type 2 diabetes. Diabetes Obes. Metab. 10, 32–42 (2008).
pubmed: 18834431
Talchai, C., Xuan, S., Lin, H. V., Sussel, L. & Accili, D. Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure. Cell 150, 1223–1234 (2012).
pubmed: 22980982 pmcid: 3445031
Masters, S. L. et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat. Immunol. 11, 897–904 (2010).
pubmed: 20835230 pmcid: 3103663
Westwell-Roper, C. Y., Ehses, J. A. & Verchere, C. B. Resident macrophages mediate islet amyloid polypeptide–induced islet IL-1β production and β-cell dysfunction. Diabetes 63, 1698–1711 (2014).
pubmed: 24222351
Nair, G. & Hebrok, M. Islet formation in mice and men: lessons for the generation of functional insulin-producing β-cells from human pluripotent stem cells. Curr. Opin. Genet. Dev. 32, 171–180 (2015).
pubmed: 25909383 pmcid: 4523641
Arrojo e Drigo, R. et al. New insights into the architecture of the islet of Langerhans: a focused cross-species assessment. Diabetologia 58, 2218–2228 (2015).
pubmed: 26215305
Unger, R. H. & Cherrington, A. D. Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover. J. Clin. Invest. 122, 4–12 (2012).
pubmed: 22214853 pmcid: 3248306

Auteurs

John T Walker (JT)

Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN, USA.

Diane C Saunders (DC)

Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Vivek Rai (V)

Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.

Hung-Hsin Chen (HH)

Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, USA.

Peter Orchard (P)

Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.

Chunhua Dai (C)

Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Yasminye D Pettway (YD)

Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN, USA.

Alexander L Hopkirk (AL)

Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Conrad V Reihsmann (CV)

Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Yicheng Tao (Y)

Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.

Simin Fan (S)

Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.

Shristi Shrestha (S)

Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Arushi Varshney (A)

Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.

Lauren E Petty (LE)

Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, USA.

Jordan J Wright (JJ)

Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Christa Ventresca (C)

Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA.

Samir Agarwala (S)

Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.

Radhika Aramandla (R)

Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Greg Poffenberger (G)

Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Regina Jenkins (R)

Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Shaojun Mei (S)

Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Nathaniel J Hart (NJ)

Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Sharon Phillips (S)

Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.

Hakmook Kang (H)

Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.

Dale L Greiner (DL)

Department of Molecular Medicine, Diabetes Center of Excellence, University of Massachusetts Medical School, Worcester, MA, USA.

Leonard D Shultz (LD)

The Jackson Laboratory, Bar Harbor, ME, USA.

Rita Bottino (R)

Imagine Pharma, Devon, PA, USA.
Institute of Cellular Therapeutics, Allegheny-Singer Research Institute, Allegheny Health Network, Pittsburgh, PA, USA.

Jie Liu (J)

Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.

Jennifer E Below (JE)

Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, USA.

Stephen C J Parker (SCJ)

Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA. scjp@umich.edu.
Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA. scjp@umich.edu.
Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA. scjp@umich.edu.

Alvin C Powers (AC)

Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN, USA. al.powers@vumc.org.
Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. al.powers@vumc.org.
VA Tennessee Valley Healthcare System, Nashville, TN, USA. al.powers@vumc.org.

Marcela Brissova (M)

Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. marcela.brissova@vanderbilt.edu.

Classifications MeSH